Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Beta-Glucan
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Concentra Educación e Investigación Biomédica
Deal Size : Inapplicable
Deal Type : Inapplicable
Beta-glucans for Hospitalised Patients With COVID-19
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 20, 2022
Lead Product(s) : Beta-Glucan
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Concentra Educación e Investigación Biomédica
Deal Size : Inapplicable
Deal Type : Inapplicable